Effect of dipeptidyl-peptidase-4 inhibitors on C-reactive protein in patients with type 2 diabetes: a systematic review and meta-analysis

BACKGROUND: Dipeptidyl peptidase-4 inhibitors (DPP-4i) are emerging glucose-lowering agents through interacting with DPP-4 substrate, impact of which on systemic inflammation in type 2 diabetes mellitus (T2DM) remains unknown. This study aimed to evaluate the effect of DPP-4i on modulating serum lev...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xin, Men, Peng, Wang, Bo, Cai, Gaojun, Zhao, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580696/
https://www.ncbi.nlm.nih.gov/pubmed/31208420
http://dx.doi.org/10.1186/s12944-019-1086-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580696/
https://www.ncbi.nlm.nih.gov/pubmed/31208420
http://dx.doi.org/10.1186/s12944-019-1086-4

Ejemplares similares